141 related articles for article (PubMed ID: 8559151)
1. The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions.
Knight DM; Wagner C; Jordan R; McAleer MF; DeRita R; Fass DN; Coller BS; Weisman HF; Ghrayeb J
Mol Immunol; 1995 Nov; 32(16):1271-81. PubMed ID: 8559151
[TBL] [Abstract][Full Text] [Related]
2. 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1.
Simon DI; Xu H; Ortlepp S; Rogers C; Rao NK
Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):528-35. PubMed ID: 9102172
[TBL] [Abstract][Full Text] [Related]
3. Platelet surface IgG in patients receiving infusions of Fab fragments of a chimaeric monoclonal antibody to glycoprotein IIb-IIIa.
Christopoulos C
Clin Exp Immunol; 1994 Oct; 98(1):6-11. PubMed ID: 7923885
[TBL] [Abstract][Full Text] [Related]
4. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets.
Wagner CL; Mascelli MA; Neblock DS; Weisman HF; Coller BS; Jordan RE
Blood; 1996 Aug; 88(3):907-14. PubMed ID: 8704248
[TBL] [Abstract][Full Text] [Related]
5. [New therapy with monoclonal antibodies--abciximab, chimeric anti-GP IIb/IIIa antibody].
Goto S
Nihon Rinsho; 2002 Mar; 60(3):492-6. PubMed ID: 11904964
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".
Reverter JC; Béguin S; Kessels H; Kumar R; Hemker HC; Coller BS
J Clin Invest; 1996 Aug; 98(3):863-74. PubMed ID: 8698879
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: a quantitative rat model of immune thrombocytopenic purpura.
Hansen RJ; Balthasar JP
J Pharmacol Exp Ther; 2001 Jul; 298(1):165-71. PubMed ID: 11408538
[TBL] [Abstract][Full Text] [Related]
8. [Construction and expression of mouse-human chimeric Fab fragment gene of monoclonal antibody SZ-2 against platelet].
Dai KS; Zhu HP; Jiang M; Ruan CG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):71-3, 79. PubMed ID: 15132913
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of a humanized anti-glycoprotein IIb/IIIa monoclonal antibody, YM337, and abciximab on in vitro antiplatelet effect and binding properties.
Suzuki K; Sato K; Kamohara M; Kaku S; Kawasaki T; Yano S; Iizumi Y
Biol Pharm Bull; 2002 Aug; 25(8):1006-12. PubMed ID: 12186399
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa.
Christopoulos C; Mackie I; Lahiri A; Machin S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):729-37. PubMed ID: 8292722
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.
Gold HK; Gimple LW; Yasuda T; Leinbach RC; Werner W; Holt R; Jordan R; Berger H; Collen D; Coller BS
J Clin Invest; 1990 Aug; 86(2):651-9. PubMed ID: 2384607
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of a single-gene mouse-human chimeric antibody against hepatitis B surface antigen.
Bose B; Khanna N; Acharya SK; Sinha S
J Gastroenterol Hepatol; 2006 Sep; 21(9):1439-47. PubMed ID: 16911690
[TBL] [Abstract][Full Text] [Related]
13. Antiaggregatory and proangiogenic effects of a novel recombinant human dual specificity anti-integrin antibody.
Escher R; Cung T; Stutz M; Haeberli A; Djonov V; Berchtold P; Hlushchuk R
J Thromb Haemost; 2009 Mar; 7(3):460-9. PubMed ID: 19054322
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody [7E3 F(ab')2] prevents arterial but not venous rethrombosis.
Sudo Y; Kilgore KS; Lucchesi BR
J Cardiovasc Pharmacol; 1995 Aug; 26(2):241-50. PubMed ID: 7475049
[TBL] [Abstract][Full Text] [Related]
15. An animal model to predict the immunogenicity of murine V regions in humans.
Cartner AM; Conry RM; Safavy A; Khazaeli MB; Sumerel LA; LoBuglio AF
Hum Antibodies Hybridomas; 1993 Oct; 4(4):174-80. PubMed ID: 8257770
[TBL] [Abstract][Full Text] [Related]
16. Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.
Batra SK; Niswonger ML; Wikstrand CJ; Pegram CN; Zalutsky MR; Morrison SL; Bigner DD
Hybridoma; 1994 Apr; 13(2):87-97. PubMed ID: 8050781
[TBL] [Abstract][Full Text] [Related]
17. Construction and characterization of a functional chimeric murine-human antibody directed against human fibrin fragment-D dimer.
Bulens F; Vandamme AM; Bernar H; Nelles L; Lijnen RH; Collen D
Eur J Biochem; 1991 Jan; 195(1):235-42. PubMed ID: 1899382
[TBL] [Abstract][Full Text] [Related]
18. Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis.
Makkar RR; Litvack F; Eigler NL; Nakamura M; Ivey PA; Forrester JS; Shah PK; Jordan RE; Kaul S
Circulation; 1997 Feb; 95(4):1015-21. PubMed ID: 9054765
[TBL] [Abstract][Full Text] [Related]
19. Intravenous administration of the glycoprotein IIb-IIIa receptor antagonist 7E3 induces reperfusion of an acute thrombotic occlusion of the canine coronary artery.
Shetler TJ; Bailey BD; Jakubowski JA; Jackson CV
Thromb Res; 1998 Apr; 90(2):95-100. PubMed ID: 9684763
[TBL] [Abstract][Full Text] [Related]
20. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins.
Tam SH; Sassoli PM; Jordan RE; Nakada MT
Circulation; 1998 Sep; 98(11):1085-91. PubMed ID: 9736595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
